Onderneming Great Novel Therapeutics Biotech & Medicals
Aandelen
7427
TW0007427007
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
49,15 TWD | -1,50% | -5,48% | -26,42% |
Vakgebied
Aantal werknemers: 12
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cancer Medical Treatment
100,0
%
| 1 | 100,0 % | 5 | 100,0 % | +798,15% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
100,0
%
| 1 | 100,0 % | 5 | 100,0 % | +798,15% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chia Nan Chen
CEO | Chief Executive Officer | - | 03-04-13 |
Ying Chang Huang
DFI | Director of Finance/CFO | - | 04-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hung Jen Wu
BRD | Director/Board Member | - | 26-09-13 |
Chung Yang Huang
BRD | Director/Board Member | - | 02-06-17 |
Tien Tzu Tseng
BRD | Director/Board Member | - | 14-05-21 |
Hung Hui Cheng
BRD | Director/Board Member | - | - |
Chia Nan Chen
CEO | Chief Executive Officer | - | 03-04-13 |
Ming Hsuan Li
BRD | Director/Board Member | - | - |
Ming I Huang
BRD | Director/Board Member | - | 02-06-17 |
Chung Hsi Chen
BRD | Director/Board Member | - | - |
Shang Pu Hsia
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 38 486 985 | 38 486 985 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Great Novel Therapeutics Biotech & Medicals Corp.
17/F, Block F, 3 Park Street Nangang District
115 03, Taipei
+
http://www.gntbm.com.twSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,42% | 58,64 mln. | |
+65,90% | 62,86 mld. | |
-1,22% | 41,38 mld. | |
+45,77% | 40,38 mld. | |
-8,93% | 27,64 mld. | |
+13,40% | 26,46 mld. | |
-22,99% | 18,9 mld. | |
+4,39% | 12,67 mld. | |
+23,14% | 12,27 mld. | |
+28,02% | 12,07 mld. |
- Beurs
- Aandelen
- Koers 7427
- Onderneming Great Novel Therapeutics Biotech & Medicals